Business Daily from THE HINDU group of publications
Saturday, May 17, 2008
ePaper | Mobile/PDA Version | Audio


News
Features
Stocks
Cross Currency
Shipping
Archives
Google

Group Sites

Corporate - Courts/Legal Issues
Markets - IPOs
Anu Lab’s option to investors

Mumbai, May 16

The Hyderabad-based Anu’s Laboratories has given investors the option to withdraw from the public issue which closed on May 15. This follows the market regulator SEBI’s advice as the company failed to disclose a pending case in its offer document. The company had received a letter on May 14 from Sunmoon Chemicals Pvt. Ltd informing that it has filed a suit. Anu’s Laboratories had received a legal notice earlier on November 2, 2007 from Sunmoon Chemicals f or a demand of Rs 46.8 lakh plus interest at 24 per cent towards three per cent commission on supplies made to a customer introduced by Sunmoon to Anu’s Labs. This case is still pending for adjudication. The company has put up a notice on the SEBI Web site giving investors the option to withdraw their bids within ten days from May 16. —

Our Bureau

.

More Stories on : Courts/Legal Issues | IPOs | Pharmaceuticals

Article E-Mail :: Comment :: Syndication :: Printer Friendly Page



Stories in this Section
Metso Minerals gets big order


Anu Lab’s option to investors
Tata Investment Corpn to raise Rs 448 cr through zero coupon convertible bonds
Texmaco shifting core engg business to subsidiary
McNally Bharat buys 68.28% stake in Sayaji Iron
Decks cleared for Hichens acquisition
Ceat setting up greenfield radial facility in Gujarat
Volvo, Eicher Motors tie-up’s ambit may be wider than truck distribution
GramIT to set up 10 more centres
MPM Capital invests $20 m in Sai Advantium
Bal Pharma stepping up export forays
SAIL scorecard


Smartbuy



The Hindu Group: Home | About Us | Copyright | Archives | Contacts | Subscription
Group Sites: The Hindu | The Hindu ePaper | Business Line | Business Line ePaper | Sportstar | Frontline | The Hindu eBooks | The Hindu Images | Home |

Copyright © 2008, The Hindu Business Line. Republication or redissemination of the contents of this screen are expressly prohibited without the written consent of The Hindu Business Line